Singapore markets closed

Vincerx Pharma, Inc. (VINC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8771-0.0529 (-5.69%)
At close: 04:00PM EDT
0.8764 -0.00 (-0.08%)
After hours: 07:55PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-40,157
-40,157
-62,984
-39,306
-16,620
Depreciation & amortisation
915
915
939
340
0
Stock-based compensation
3,563
3,563
10,056
23,313
4,382
Change in working capital
-4,191
-4,191
-1,020
5,609
-959
Accounts payable
-1,568
-1,568
1,046
1,528
456
Other working capital
-40,453
-40,453
-59,604
-38,660
-2,279
Other non-cash items
-
-
-
-
5,782
Net cash provided by operating activities
-40,453
-40,453
-59,604
-33,402
-2,279
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-5,258
-
Purchases of investments
-11,821
-11,821
-42,978
0
-
Sales/maturities of investments
53,321
53,321
2,400
0
-
Net cash used for investing activities
41,500
41,500
-40,578
-5,258
0
Cash flows from financing activities
Debt repayment
-
-
-
-
-300
Common stock issued
-
-
0
47,431
0
Other financing activities
-
-
-
-
64,071
Net cash used provided by (used for) financing activities
114
114
280
88,453
64,071
Net change in cash
1,121
1,121
-99,831
49,772
61,792
Cash at beginning of period
11,733
11,733
111,564
61,792
0
Cash at end of period
12,854
12,854
11,733
111,564
61,792
Free cash flow
Operating cash flow
-40,453
-40,453
-59,604
-33,402
-2,279
Capital expenditure
-
-
-
-5,258
-
Free cash flow
-40,453
-40,453
-59,604
-38,660
-2,279